Don't Rush That to the Clinic Just Yet
In Self-Perpetuating Cycle, Biomarkers Often Oversold
By Anette Breindl
Thursday, June 2, 2011
High hopes are riding on biomarkers. By stratifying patient populations and bringing the right drug to the right patient at the right time, the idea goes, biomarkers will be critical to the success of personalized medicine. As a result, there is a veritable parade of biomarkers in the scientific literature.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.